Jim Cramer is seeing some good signs in the economy right now. Could they be the perfect ingredients for a Santa Claus rally?» Read More
Jim Cramer takes a close look under the market's hood and makes a big discovery that could impact your portfolio.
As the global economy faces headwinds each day, Jim Cramer knows this group can withstand stormy weather more often than the rest.
Nov 26- The board of Teva Pharmaceutical Industries Ltd elected Yitzhak Peterburg as its chairman, succeeding Phillip Frost, who is due to step down at the end of the year. The company also appointed Sol Barer, the former chief executive of Celgene Corp, as a director. Teva stock was up 0.8 percent at $57.02 on the New York Stock Exchange.
Actavis Plc, Gilead Sciences, Celgene and other biotech names were among the S&P 500' s biggest drivers, a day after Allergan agreed to be bought by Actavis. The S&P health care index was up 1.6 percent, while shares of Actavis were up 8.3 percent, Gilead's rose 3.3 percent and shares of Celgene were up 2.4 percent. Helping Actavis were bullish analyst notes.
Actavis Plc, Gilead, Celgene and other biotech names were among the S&P 500' s biggest drivers, a day after Allergan agreed to be bought by Actavis. The S&P health care index was up 1.4 percent, while shares of Actavis were up 7.7 percent, Gilead's rose 2.9 percent and shares of Celgene were up 2.4 percent. Helping Actavis were bullish analyst notes.
Some of Friday's midday movers:
Think that the market was uneventful on Tuesday? Not so fast, Jim Cramer sees these three sectors growing fast, which could lead to profits.
Jim Cramer focuses on three long-term investment themes specialized for veterans and active-duty soldiers.
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Don't worry, be happy. Jim Cramer says these stocks are not affected by the Federal Reserve's announcement to end its bond buying program.
Oct 27- Amgen Inc on Monday reported higher-than-expected third quarter profit and revenue, helped by strong demand for its white blood cell booster, Neulasta, and increased sales of newer drugs, and the company raised its full-year forecast. Amgen shares are up almost 20 percent since the restructuring announcement that involved plant closings and the...
Oct 24- Amgen Inc, one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund. In a letter to investors on Tuesday, Loeb said Amgen has "all the hallmarks of a hidden value situation" and should divide...
*IBM slumps after quarterly results. NEW YORK, Oct 20- U.S. stocks ended higher on Monday on investor hopes for a strong earnings season, but IBM's disappointing results limited gains. IBM shares slumped 7.1 percent to $169.10, the biggest drag on both the Dow and S&P 500, after third-quarter earnings fell well short of Wall Street expectations.
All too often, investors throw out the proverbial baby with the bathwater. Cramer would hate to see some of them lost down the drain.
An undercurrent that’s been sorely missing from the stock market resurfaced on Wednesday. Cramer thinks you should factor it into your next move.
If you’re looking for stock ideas, Cramer says thanks to good ol’ American ingenuity, this sector is bursting with them.
Check out which companies are making headlines after the bell Tuesday:Bed Bath & Beyond, Viacom, Starbucks & more.
Jim Cramer is always looking near and far for ideas. He just found something big.
Cramer thinks pros are so eager to buy Alibaba they’re willing to throw away perfectly good stocks. That’s silly.
As the Alibaba IPO nears, Cramer expects a slew of stocks to selloff. He's naming names.